CMG Pharmaceutical Co., Ltd. (058820.KQ) KOE
Currency In KRW
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In KRW
Address
Cheongdam-dong 18-20, #B01
Seoul, 135-949
Korea (the Republic of)
Phone
82 3 1881 7600
Website
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
273
First IPO Date
November 19, 2001
| Name | Title | Pay | Year Born |
| Joohyung Lee | Chief Executive Officer | 0 | N/A |
| Hyeongnam Kim | Managing Director | 0 | N/A |
| Joong-Hwan Bae | Head of Management Supporting Team and Director | 0 | 1954 |
Based in Seoul, South Korea, CMG Pharmaceutical Co., Ltd. operates as a pharmaceutical firm dedicated to the research, development, and sale of innovative oral thin film (OTF) medications. Its diverse product portfolio features OTF formulations such as Tadalafil for addressing erectile dysfunction, Entecavir for managing hepatitis B, Aripiprazole for treating schizophrenia, and Montelukast for alleviating asthma and allergic rhinitis. The company also engages in a strategic partnership with Handok Inc., focusing on advancements in cancer treatment. Established in 2001, the enterprise was formerly recognized as Skynewpharm Co Ltd before officially becoming CMG Pharmaceutical Co., Ltd. in April 2013.